-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives $13.31 Consensus PT from Analysts
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned a consensus recommendation of “Hold” from the twelve ratings firms that are currently covering the firm, Marketbeat reports. Twelve equities research analysts have rated the stock with a hold recommendation. The average twelve-month target price among analysts that have covered the stock in […]
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned a consensus recommendation of “Hold” from the twelve ratings firms that are currently covering the firm, Marketbeat reports. Twelve equities research analysts have rated the stock with a hold recommendation. The average twelve-month target price among analysts that have covered the stock in […]
